Acetylsalicylic acid Recruiting Phase 1 Trials for Aorta-iliac Segment Lesion (C,D Type by TASC II) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02209350Study of the AFB and Stenting of the Iliac Arteries